TY - JOUR
T1 - Non-motor multiple system atrophy associated with sudden death
T2 - pathological observations of autonomic nuclei
AU - Riku, Yuichi
AU - Watanabe, Hirohisa
AU - Mimuro, Maya
AU - Iwasaki, Yasushi
AU - Ito, Mizuki
AU - Katsuno, Masahisa
AU - Sobue, Gen
AU - Yoshida, Mari
N1 - Publisher Copyright:
© 2017, Springer-Verlag GmbH Germany.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - Multiple system atrophy (MSA) manifests as a combination of dysautonomia and motor symptoms/signs. However, rare cases presenting with autonomic failures in absence of motor symptoms/signs until their deaths have been reported and are referred to as non-motor MSA. To clarify pathological findings underlying non-motor MSA patients, we analyzed consecutively autopsied 161 patients with MSA. In results, four patients were identified as having non-motor MSA, who showed isolated autonomic disorders throughout their lives and had minimal pathological changes in the motor systems. We also identified two patients with pathologically minimal MSA, who had minimal pathological involvement in the motor systems and presented with definite parkinsonism and dysautonomia. Survival durations of the non-motor MSA patients were much shorter (1.3–2.0 years) than those of the classical MSA patients (3.0–7.0 years), and the causes of death were all sudden death. The medullary serotonergic neurons were severely involved in the non-motor MSA patients in comparison with the classical MSA patients. Also, one of the pathologically minimal MSA patients had died suddenly and exhibited marked involvement of the medullary serotonergic neurons. The involvement of the medullary catecholaminergic or cholinergic neurons did not differ in severities among the groups. We conclude that non-motor MSA may be a pathological variant of MSA that preferentially involves the medullary serotonergic neurons and autonomic systems in association with poor prognosis.
AB - Multiple system atrophy (MSA) manifests as a combination of dysautonomia and motor symptoms/signs. However, rare cases presenting with autonomic failures in absence of motor symptoms/signs until their deaths have been reported and are referred to as non-motor MSA. To clarify pathological findings underlying non-motor MSA patients, we analyzed consecutively autopsied 161 patients with MSA. In results, four patients were identified as having non-motor MSA, who showed isolated autonomic disorders throughout their lives and had minimal pathological changes in the motor systems. We also identified two patients with pathologically minimal MSA, who had minimal pathological involvement in the motor systems and presented with definite parkinsonism and dysautonomia. Survival durations of the non-motor MSA patients were much shorter (1.3–2.0 years) than those of the classical MSA patients (3.0–7.0 years), and the causes of death were all sudden death. The medullary serotonergic neurons were severely involved in the non-motor MSA patients in comparison with the classical MSA patients. Also, one of the pathologically minimal MSA patients had died suddenly and exhibited marked involvement of the medullary serotonergic neurons. The involvement of the medullary catecholaminergic or cholinergic neurons did not differ in severities among the groups. We conclude that non-motor MSA may be a pathological variant of MSA that preferentially involves the medullary serotonergic neurons and autonomic systems in association with poor prognosis.
UR - http://www.scopus.com/inward/record.url?scp=85029738316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029738316&partnerID=8YFLogxK
U2 - 10.1007/s00415-017-8604-y
DO - 10.1007/s00415-017-8604-y
M3 - Article
C2 - 28939940
AN - SCOPUS:85029738316
SN - 0340-5354
VL - 264
SP - 2249
EP - 2257
JO - Journal of Neurology
JF - Journal of Neurology
IS - 11
ER -